Cardio Diagnostics-CW26CDIOWPreferred / convertible
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 10 institutions reported holding Cardio Diagnostics-CW26 (CDIOW) in their 13F filings, up 1 from Q2 2024. 2 opened new positions and 1 sold out. The largest holders were Boothbay Fund Management, LLC ($14K), Walleye Capital LLC ($9K) and Saba Capital Management, L.P. ($8K). 2 famous investors held it, including David E. Shaw ( of D. E. Shaw & Co.'s portfolio) and Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Cardio Diagnostics-CW26
- CUSIP
- 14159C111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3K |
| Exits | 1 | $1K |
All 13F filers, Q2 2024 → Q3 2024: 72,171 shares bought and 36,264 shares sold, net +35,907 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Boothbay Fund Management, LLC | — | No change | 60,540 | $14K |
| Walleye Capital LLC | — | No change | 234,907 | $9K |
| Saba Capital Management, L.P. | — | No change | 199,839 | $8K |
| Walleye Trading LLC | — | No change | 132,265 | $5K |
| Clear Street LLC | — | No change | 83,042 | $3K |
| Context Capital Management, LLC | — | No change | 81,500 | $3K |
| D. E. Shaw & Co. | — | No change | 74,822 | $3K |
| Atw Spac Management LLC | — | New | 60,540 | $2K |
| Citadel Advisors | — | New | 11,631 | $454 |
| UBS Group AG | — | Reduce -2.6% | 9,737 | $380 |
"% of holder's portfolio" is CDIOW's weight in each manager's 13F, not the share of Cardio Diagnostics-CW26 the manager owns.